| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Fan Dong CEO | XSHE Exchange | CNE100002995 ISIN |
| CN Country | 2,797 Employees | 1 Jun 2026 Last Dividend | 20 May 2020 Last Split | - IPO Date |
Jafron Biomedical Co., Ltd. is a pioneering enterprise specializing in the domain of blood purification technologies. Established in 1989 and headquartered in Zhuhai, China, the company has dedicated itself to the research, development, production, and international sales of blood purification products within the hemadsorption industry. It addresses a broad spectrum of medical needs, ranging from End-Stage Renal Disease (ESRD) and acute poisoning to critical illnesses, liver disorders, immunological dysfunctions, and kidney and liver diseases. Jafron Biomedical has carved a niche for itself on a global scale, signifying its contribution to advancing medical treatment and patient care.
Jafron Biomedical Co.,Ltd. offers an array of specialized products and services catered towards improving patient outcomes in multiple medical scenarios. Each of these offerings is designed with the latest advancements in medical technology and research: